Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

CDC Seeking $400 Million To Replace Lab For Deadliest Germs

February 27, 2018 By Mike Stobbe, AP Medical Writer

Thirteen years after building a state-of-the-art lab for the world’s most dangerous germs, the nation’s top public health agency is asking for more than $400 million to build a new one.

Officials at the Centers for Disease Control and Prevention say the current lab building in Atlanta is quickly wearing down, and cannot be upgraded without shutting down the facility for years. The lab investigates deadly and exotic germs like Ebola, smallpox and dangerous new forms of flu.

The agency disclosed its plans for a new lab on Friday.

The CDC lab is one of only eight U.S. labs with the security and safety features necessary to work with the highest-threat germs, said James Le Duc, director of one of them, the University of Texas’s Galveston National Laboratory. Five of the eight are run by the federal government.

The lab is housed in a 400,000-square-foot concrete building located in the heart of the CDC’s main campus. It uses eye scanners and other James Bond-like security measures to restrict access. Workers wear protective gear and there’s a web of computerized systems that monitor workers, lock doors, and ensure that dangerous germs don’t escape.

It opened in 2005 and cost $214 million, although the lab area that handles the most fearsome bugs didn’t begin work until 2009. It replaced a CDC lab that had operated for 20 years. The architect firm that worked on it, HDR Inc., predicted the building would serve the CDC for 50 years.

This Sep. 9, 2005, photo provided by the Center for Disease Control and Prevention shows the then newly constructed 11-story Emerging Infectious Diseases Laboratory located at the CDC’s Roybal campus in Atlanta. Thirteen years after building the state-of-the-art lab for the world’s most dangerous germs, the nation’s top public health agency is asking for more than $400 million to build a new one. CDC is asking Congress for the money. Its officials say the current lab building in Atlanta is quickly wearing down, and cannot be upgraded without shutting down the facility for years. (Center for Disease Control and Prevention via AP)

Some experts said they are a little surprised CDC is talking about replacing the high-containment lab so soon.

“Having a lab being replaced after about 12 years seems unusual,” said Stephen Higgs, director of the Biosecurity Research Institute at Kansas State University.

Some parts needed at the CDC lab are no longer made and engineers determined a new building is necessary because of the complexity of the systems, said Dr. Inger Damon, who oversees much of the lab work involving dangerous germs.

It will take four years to construct a new building and related infrastructure, so the money is needed now, CDC officials said. The CDC is asking Congress for $350 million for the lab and more than $50 million for related work. Government officials last week approached Congress about a plan to fund the CDC project with discretionary funds.

“The longer it takes, the more likely there will be a failure. And if there’s a failure, we lose an essential line of defense” against disease threats, said the CDC’s former director, Dr. Tom Frieden.

A number of problems have been reported over the years in the building, including a 2009 decontamination shower failure and a 2015 fire in a lower-level lab. But Frieden said overall the facility has performed well and the incidents were not the reason for the replacement plans.

Related Articles Read More >

This is a Zimmer Biomet marketing image of its Rosa robotic surgery system.
Zimmer Biomet seeks a ZBEdge for its Rosa robotic surgery
A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe